Filing Flows › Comparisons › MBOT vs CODX
Microbot Medical vs Co-Diagnostics: MBOT and CODX compared
Microbot Medical is the larger company: $241K of revenue in its latest quarter (Q2 2026) against $166K for Co-Diagnostics (Q2 2026).
Where the money goes: MBOT and CODX
Microbot Medical (MBOT) · Q2 2026
Microbot Medical, Q2 2026: revenue $241K, net loss $5.6M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
Co-Diagnostics (CODX) · Q2 2026
Co-Diagnostics, Q2 2026: revenue $166K (+2% year over year), net loss $6.3M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
| Microbot Medical (MBOT) | Co-Diagnostics (CODX) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $241K | $166K |
| Revenue growth, Y/Y | — | +2% |
| Operating margin | n/m | n/m |
| Net earnings | −$5.6M | −$6.3M |
| Operating cash flow | −$5.0M | −$7.2M |
Questions
Which is bigger, Microbot Medical or Co-Diagnostics?
Microbot Medical is the larger company: $241K of revenue in its latest quarter (Q2 2026) against $166K for Co-Diagnostics (Q2 2026).
More: Microbot Medical earnings · how Microbot Medical makes money · Co-Diagnostics earnings · how Co-Diagnostics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 11, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.